IGHE and Alzheimer disease: Altogether, elevated expression levels of IL-38 in the sera of patients with AD can potentiate the specificity of eosinophilic count and IgE as inducer agents of TH2 responses, presenting IL-38 as a prognostic seroimmunobiomarker for disease severity [105].